PT1073413E - Metodos e composicoes para estabilizacao de composicoes de acetilcolina - Google Patents

Metodos e composicoes para estabilizacao de composicoes de acetilcolina

Info

Publication number
PT1073413E
PT1073413E PT99923472T PT99923472T PT1073413E PT 1073413 E PT1073413 E PT 1073413E PT 99923472 T PT99923472 T PT 99923472T PT 99923472 T PT99923472 T PT 99923472T PT 1073413 E PT1073413 E PT 1073413E
Authority
PT
Portugal
Prior art keywords
acetylcholine
compositions
buffered
product
stabilization
Prior art date
Application number
PT99923472T
Other languages
English (en)
Inventor
Fu-Pao Tsao
Minno George Edward
Original Assignee
Novartis Ag
Novartis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Novartis Pharma Gmbh filed Critical Novartis Ag
Publication of PT1073413E publication Critical patent/PT1073413E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymerisation Methods In General (AREA)
PT99923472T 1998-04-29 1999-04-27 Metodos e composicoes para estabilizacao de composicoes de acetilcolina PT1073413E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6955298A 1998-04-29 1998-04-29

Publications (1)

Publication Number Publication Date
PT1073413E true PT1073413E (pt) 2005-04-29

Family

ID=22089751

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99923472T PT1073413E (pt) 1998-04-29 1999-04-27 Metodos e composicoes para estabilizacao de composicoes de acetilcolina

Country Status (25)

Country Link
US (1) US6261546B1 (pt)
EP (1) EP1073413B1 (pt)
JP (1) JP2002512945A (pt)
KR (1) KR100617429B1 (pt)
CN (1) CN1147289C (pt)
AT (1) ATE286380T1 (pt)
AU (1) AU745124B2 (pt)
BR (1) BR9910077A (pt)
CA (1) CA2327398C (pt)
CZ (1) CZ301969B6 (pt)
DE (1) DE69923063T2 (pt)
EE (1) EE04515B1 (pt)
ES (1) ES2235486T3 (pt)
HK (1) HK1034204A1 (pt)
HU (1) HU226104B1 (pt)
ID (1) ID26032A (pt)
IL (1) IL138775A0 (pt)
NO (1) NO20005372L (pt)
NZ (1) NZ507074A (pt)
PL (1) PL194092B1 (pt)
PT (1) PT1073413E (pt)
RU (1) RU2225199C2 (pt)
SI (1) SI1073413T1 (pt)
UA (1) UA72209C2 (pt)
WO (1) WO1999055304A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101595108A (zh) * 2006-11-30 2009-12-02 日本医事物理股份有限公司 对淀粉状蛋白具有亲和性的新化合物
US20130029919A1 (en) * 2011-07-26 2013-01-31 Allergan, Inc. Two part formulation system for opthalmic delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5009892A (en) * 1989-03-03 1991-04-23 Mckinzie James W Rapid miosis with control of intraocular pressure
US5565188A (en) 1995-02-24 1996-10-15 Nanosystems L.L.C. Polyalkylene block copolymers as surface modifiers for nanoparticles
US5612027A (en) 1995-04-18 1997-03-18 Galin; Miles A. Controlled release of miotic and mydriatic drugs in the anterior chamber

Also Published As

Publication number Publication date
RU2225199C2 (ru) 2004-03-10
CA2327398C (en) 2008-12-30
HK1034204A1 (en) 2001-10-19
CA2327398A1 (en) 1999-11-04
EE200000625A (et) 2002-02-15
AU4034099A (en) 1999-11-16
WO1999055304A1 (en) 1999-11-04
HUP0100613A3 (en) 2001-12-28
PL343174A1 (en) 2001-07-30
EP1073413B1 (en) 2005-01-05
DE69923063T2 (de) 2005-12-22
BR9910077A (pt) 2000-12-26
ES2235486T3 (es) 2005-07-01
US6261546B1 (en) 2001-07-17
KR100617429B1 (ko) 2006-08-30
EE04515B1 (et) 2005-08-15
ID26032A (id) 2000-11-16
HU226104B1 (en) 2008-04-28
EP1073413A1 (en) 2001-02-07
CN1298295A (zh) 2001-06-06
NZ507074A (en) 2004-02-27
NO20005372D0 (no) 2000-10-25
ATE286380T1 (de) 2005-01-15
AU745124B2 (en) 2002-03-14
NO20005372L (no) 2000-10-25
DE69923063D1 (de) 2005-02-10
HUP0100613A2 (hu) 2001-08-28
PL194092B1 (pl) 2007-04-30
JP2002512945A (ja) 2002-05-08
CZ301969B6 (cs) 2010-08-18
CN1147289C (zh) 2004-04-28
CZ20003961A3 (cs) 2001-01-17
UA72209C2 (en) 2005-02-15
SI1073413T1 (pt) 2005-08-31
KR20010043121A (ko) 2001-05-25
IL138775A0 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
ATE209206T1 (de) Heterocyclisch substituierte cyclopentanderivate.
PT98905A (pt) Processo para a preparacao de mono-hidrato de furoato de mometasona,e de composicoes farmaceuticas que o contem
TR200100366T2 (tr) Aktif madde dağıtmaya mahsus bileşikler ve bileşimler.
CO5070657A1 (es) Composiciones farmaceuticas para tratar infecciones virales y metodo para hacerlas
CA2200195A1 (en) Use of aromatase inhibitors for the production of a pharmaceutical agentfor treating a relative androgen deficiency in men
WO2002028829A3 (en) Peptide deformylase inhibitors
ATE229340T1 (de) Relaxinartiger faktor und damit zusammenhängende verfahren und verwendungen
TW268937B (pt)
DE69906345D1 (de) Zusammensetzung zur behandlung und prävention neurologischer und pathopsychologischer krankheiten
JO1696B1 (en) Acetamide derivatives
WO2001087287A3 (en) Use of pyrazole derivatives for treating infertility
TR200100895T2 (tr) Heterosiklik ikameli propanolamin türevleri, üretimi, ilaçları,kullanımı
DE69614824D1 (de) Verfahren zur herstellung von retrovial protease hemmenden zwischenprodukten
ES2111272T3 (es) Mezclas herbicidas.
PT1073413E (pt) Metodos e composicoes para estabilizacao de composicoes de acetilcolina
ATE293964T1 (de) Zusammensetzungen und verfahren zur behinderung der entladung von nematokyste
CA2296560A1 (en) Amino acid derivatives useful to treat stroke
WO2004078180A3 (en) Naaladase inhibitors for treating opioid tolerance
DE69626544D1 (de) Arzneistoffe
WO2003041640A3 (en) METHODS FOR TREATING ISCHEMIC REPERFUSION INJURY USING IkB KINASE-BETA INHIBITORS
ATE477324T1 (de) Dna-enzym zur hemmung von plasminogenaktivator- inhibitor-1
EA200200775A1 (ru) Псевдополиморф (-)-цис-2-(2-хлорфенил)-5,7-дигидрокси-8[4r-(3s-гидрокси-1-метил)пиперидинил]-4h-1-бензопиран-4-она
WO1999025327A3 (en) Small molecule intervention in hiv-1 replication
RU95106624A (ru) Гидроксиэтиламиносульфонамиды, промежуточные соединения, фармацевтическая композиция, способ ингибирования ретровирусных протеаз, способ лечения ретровирусных инфекций, способ лечения спида
RU93055684A (ru) Соединения, ингибирующие вич-протеазу, способ их получения, фармацевтическая композиция, промежуточный продукт